Predictive Performance and Rater Reliability of CT-derived Virtual Reality Models for PDA Stent Planning in Patients with Ductal-Dependent Cyanotic Congenital Heart Disease
Pediatric Cardiology · 2026
DOI: 10.1007/s00246-025-04042-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, 2026. Verfasst von Ashish Saini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Children's Healthcare of Atlanta, 2220 N Druid Hills Rd NE, Atlanta, GA, 30329, USA. sainia@kidsheart.com. Hauptthemen laut MEDLINE: Stents, Ductus Arteriosus, Patent, Virtual Reality, Cardiac Catheterization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Transcatheter patent ductus arteriosus (PDA) stenting is a key palliative strategy for ductal-dependent cyanotic congenital heart disease (CHD). This study assessed the feasibility of generating 3-dimensional (3D) virtual reality (VR) models, evaluated their predictive performance for predicting vascular access and stent size, and examined inter- and intra-rater reliability of VR ductal measurements. This retrospective study included 42 infants (January 2021-December 2024) with pre-procedural cardiac CT (CCT) who underwent PDA stenting for ductal-dependent pulmonary circulation. 3D VR PDA and PDA stent models in 4 mm length increments were generated using commercial software. A blinded interventional cardiologist predicted optimal vascular access and stent size. VR-based recommendations were compared to procedural outcomes. Two blinded operators independently measured total length (TL), straight length (SL), and ductal curvature index (CI) in VR; reliability was assessed by intraclass correlation coefficients (ICCs). VR models were successfully generated for all patients. The mean age and weight at procedure were 8.1 ± 4.7 days and 3.2 ± 0.6 kg, respectively. VR-predicted vascular access matched actual access in 36 (85.7%) cases. Stent size prediction matched deployed stents in 15 (35.7%) cases and was ± one size category in an additional 22 (52.4%) cases (88.1% total cases within one size category of deployed stent). Intra-rater ICCs were > 0.926; inter-rater ICCs were > 0.977. In conclusion, high-fidelity VR models are feasible for PDA stent planning, demonstrate high predictive performance for vascular access, and have excellent rater reliability for ductal measurements. This supports integrating VR modeling into pre-procedural workflows to improve planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Children's Healthcare of Atlanta, 2220 N Druid Hills Rd NE, Atlanta, GA, 30329, USA. sainia@kidsheart.com.
- Emory University School of Medicine, Atlanta, GA, USA. sainia@kidsheart.com.
- Division of Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- Division of Cardiology, Children's Healthcare of Atlanta, 2220 N Druid Hills Rd NE, Atlanta, GA, 30329, USA.
- Emory University School of Medicine, Atlanta, GA, USA.
Zitieren
APA
Saini, A., Hashemi, S., McEachern, W., Ligon, R. A., & Wilson, H. C. (2026). Predictive Performance and Rater Reliability of CT-derived Virtual Reality Models for PDA Stent Planning in Patients with Ductal-Dependent Cyanotic Congenital Heart Disease. Pediatric Cardiology. https://doi.org/10.1007/s00246-025-04042-w
Vancouver
Saini A, Hashemi S, McEachern W, Ligon RA, Wilson HC. Predictive Performance and Rater Reliability of CT-derived Virtual Reality Models for PDA Stent Planning in Patients with Ductal-Dependent Cyanotic Congenital Heart Disease. Pediatric Cardiology. 2026. doi:10.1007/s00246-025-04042-w
BibTeX
@article{Saini2026,
author = {Saini, Ashish and Hashemi, Sassan and McEachern, William and Ligon, R Allen and Wilson, Hunter C},
title = {Predictive Performance and Rater Reliability of CT-derived Virtual Reality Models for PDA Stent Planning in Patients with Ductal-Dependent Cyanotic Congenital Heart Disease},
journal = {Pediatric Cardiology},
year = {2026},
doi = {10.1007/s00246-025-04042-w}
}
EUVIMED